Suzanne Sexton, SLP in Laurel, MD - Speech-Language Pathologist

Suzanne Sexton, SLP is a Speech-language Pathologist based in Laurel, Maryland. Suzanne Sexton is licensed to practice in Maryland (license number 06025) and her current practice location is 14409 Greenview Dr, Ste 102, Laurel, Maryland. She can be reached at her office (for appointments etc.) via phone at (301) 498-8100.

NPI number for Suzanne Sexton is 1144598624 and her current mailing address is 14409 Greenview Dr, Ste 102, Laurel, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1144598624.

Contact Information

	Suzanne Sexton, SLP
	14409 Greenview Dr, Ste 102, Laurel, MD 20708-3293
	(301) 498-8100
	(301) 498-0800

Healthcare Provider's Profile

Full Name	Suzanne Sexton
Gender	Female
Speciality	Speech-language Pathologist
Location	14409 Greenview Dr, Laurel, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1144598624
Provider Enumeration Date: 12/12/2011
Last Update Date: 12/12/2011

Medical Identifiers

Medical identifiers for Suzanne Sexton such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1144598624	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	06025 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Suzanne Sexton is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Suzanne Sexton, SLP 14409 Greenview Dr, Ste 102, Laurel, MD 20708-3293 Ph: (301) 498-8100	Suzanne Sexton, SLP 14409 Greenview Dr, Ste 102, Laurel, MD 20708-3293 Ph: (301) 498-8100

News Archive

FDA allows GeoVax Labs to commence phase 1 clinical trial for HIV/AIDS therapeutic vaccine

GeoVax Labs, Inc., a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, is now allowed by the FDA to begin a phase 1 clinical trial for GeoVax's therapeutic vaccine, which is intended as a treatment for individuals infected with HIV. The company will begin a non-blinded study in HIV infected individuals who started drug treatment during their first year of infection.

WaferGen Bio-systems signs collaboration agreement with Luxembourg Institute of Health

WaferGen Bio-systems announced today that the Company has signed a collaboration agreement with the Luxembourg Institute of Health, a leading public medical research center that specializes in oncology, infectious diseases, immunology, and population health.

Efficient, sensitive and robust Chromatin immunoprecipitation methods

Chromatrap®, a business unit of Porvair Sciences, has produced a new 10-page brochure that provides an informative introduction to chromatin immunoprecipitation (ChIP) technology and a detailed comparison of traditional bead based and Chromatrap® solid state ChIP technologies.

EMA approves TWYNSTA therapy that reduces BP in hypertensive patients

Boehringer Ingelheim announced today that the European Commission confirmed the positive opinion of the European Medicines Agency (EMA) approving TWYNSTA. TWYNSTA is indicated for the treatment of hypertension in adults whose blood pressure is not adequately controlled on amlodipine or as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets containing the same component doses.

Triple-negative breast cancer patients may have unique biomarker to receive targeted therapy: Research

Patients with triple negative breast cancer, one of the hardest subtypes to treat, may have a unique biomarker that would enable them to receive more targeted therapy, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

Speech-Language Pathologist in Laurel, MD

Brittany Cherise Barnes, MA-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr Ste 102, Laurel, MD 20708 Phone: 301-498-8100 Fax: 301-498-0009
Cameron Carbrey, SLP-L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr Ste 102, Laurel, MD 20708 Phone: 301-498-8100
Kristina Kubistal, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr Ste 102, Laurel, MD 20708 Phone: 301-498-8100
Dorinda Malcolm, M.A.,CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 8644 Water Fall Dr, Laurel, MD 20723 Phone: 443-718-3176
Hannah Dick, MS, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr Ste 102, Laurel, MD 20708 Phone: 301-498-8100
Hannah Hoyns, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr Ste 102, Laurel, MD 20708 Phone: 301-498-8100 Fax: 301-498-0009
Susan Levine, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr Ste 102, Laurel, MD 20708 Phone: 301-498-8100 Fax: 301-498-0009

Suzanne Sexton, SLP - Speech-Language Pathologist in Laurel, MD